Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
about
Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometryAn integrative proteomics and interaction network-based classifier for prostate cancer diagnosisNovel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.A comprehensive analysis and annotation of human normal urinary proteome.Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS.Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive proteinOne-step sample concentration, purification, and albumin depletion method for urinary proteomics.Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.Quantitative mass spectrometry of urinary biomarkersProfilin 1 is a potential biomarker for bladder cancer aggressivenessMolecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsUrine in clinical proteomics.Challenges in cancer research and multifaceted approaches for cancer biomarker quest.Urinary proteomic profiling for diagnostic bladder cancer biomarkers.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.Molecular markers in bladder cancer: Novel research frontiers.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder CancerDeciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles.Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.High-resolution proteomics and metabolomics in thyroid cancer: Deciphering novel biomarkers.Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.Back to the future in bladder cancer research.
P2860
Q24645983-D1A62194-45DC-4C19-A51D-14B3BBEC322DQ28533442-B0477BBA-45B2-4006-9A97-952FD922707DQ33632731-96C620DA-0CFA-464B-8ACF-56167F4A5C25Q33780112-D2A211D4-186F-461A-8844-6C1A6ABA1A68Q33815416-5ADE6454-53CA-4BF3-93DF-2EC54A45A72FQ33976936-C5A3DB67-7BA0-44E3-801C-61D1864C3D42Q33977711-0906DA4A-A9FD-4207-B60A-264F0D541138Q34283119-E46EC606-351F-4AD0-8588-7CD190E098F2Q34401768-155E1A08-0996-42AA-86E0-C6CD5168A302Q34735798-48493E8E-01D6-4E10-8C7A-50A3156ADD14Q34987865-FA0C1292-85DA-42CD-9A49-99FDB69E597FQ35198309-39942F3D-F7DD-49D1-A2CA-DFED15763315Q35599113-CEB05AD0-06F7-4AA5-9C0B-4AAA572354A7Q35878733-E0563909-C3BD-4C2F-82CC-7856C83B3F39Q36190604-033971AB-4DDF-4E9E-8898-C17934A374BBQ36770389-B995D90D-E4E8-4363-AF36-7A955584C611Q37230698-D0F32000-11DC-4934-B3A3-1E42980CC5E8Q37425361-5B1E56B2-B10E-47F6-A81A-FA2DC65986AFQ37610310-42568A7D-E840-4E43-9CD8-C7108D3C0838Q37714579-6FF6F110-5574-4DAB-8D37-D5CDDC5B5383Q37810251-B2DE337A-2EBC-45F5-BDD8-43E270E17D99Q37876853-1A445876-C384-441E-8B9A-B91AC70C0029Q38520403-F88DCC61-5EA0-41BD-9FCF-E39D064C9EEEQ38921522-543D227D-055B-4176-896B-E38FD99A5A39Q39053492-0E5C576E-6F56-4EE3-A09F-349272AF0ACCQ39165376-06096022-031B-41E6-9121-1A1AA2C6D227Q47287949-4B4A6475-18CC-42E2-B02E-ED336EDCA6BFQ47826917-8D5A4D39-AE49-4E9F-9836-F23A7C67C3EDQ47832950-CCC43EBD-3B48-412D-BB56-F8C139351045Q50256258-4C9F0E8D-5302-4AA2-8E13-69FEC20E4C78Q51700873-05A3ECF3-745C-41E9-9870-3CE3EE8E6921
P2860
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@ast
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@en
Searching urinary tumor marker ...... fferential gel electrophoresis
@nl
type
label
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@ast
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@en
Searching urinary tumor marker ...... fferential gel electrophoresis
@nl
prefLabel
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@ast
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@en
Searching urinary tumor marker ...... fferential gel electrophoresis
@nl
P2093
P356
P1476
Searching urinary tumor marker ...... rophoresis (2D-DIGE) approach.
@en
P2093
Alvaro Serrano
Esteban Orenes-Piñero
Ferrán Algaba
Ignacio Casal
Marta Cortón
Marta Sánchez-Carbayo
Pilar González-Peramato
P304
P356
10.1021/PR070368W
P577
2007-09-29T00:00:00Z